David W. M. Muller walks C. Michael Gibson through the 1 year results from the TENDYNE trial using a new transcatheter device for mitral valve replacement TENDYNE: 1-Year Outcomes of Transcatheter MV ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果当前正在显示可能无法访问的结果。
隐藏无法访问的结果